로딩 중…
지수 로딩 중…
Hana Pharm. Co., Ltd.
293480· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,980-2.39%
2026-06-19
Price Chart
Hana Pharm. Co., Ltd.-27.29%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 159.60B KRW |
| Revenue | 244.29B KRW |
| Net Income | 3.27B KRW |
| Total Assets | 439.19B KRW |
| Net Assets | 319.51B KRW |
| Employees | 730 |
| Value | |
| P/E | 48.83x |
| P/B | 0.50x |
| PEG | 0.36x |
| P/S | 0.65x |
| EV/EBITDA | 30.26x |
| FCF Yield | 4.68% |
| Profitability | |
| ROE | 1.02% |
| ROA | 0.74% |
| Op. Margin | 2.99% |
| Revenue Growth | 8.32% |
| Earnings Growth | 135.92% |
| Financial Health | |
| Debt Ratio | 37.46% |
| Total Debt | 63.80B KRW |
| FCF | 7.47B KRW |
| Cash | 2.34B KRW |
| Current Ratio | 1.40x |
| Net Debt/EBITDA | 8.41x |
| Dividend | |
| Div. Yield | 2.83% |
| Div. Growth | -49.02% |
| Performance | |
| 1Y Return | -27.29% |
| 1M Return | -8.65% |
| From 52W High | -28.16% |
| 1Y MDD | -28.96% |
| Trading | |
| Volume | 19,124 shares |
| Foreign Own. | 0.00% |
| Per Share | |
| EPS | 818 KRW |
| BPS | 18,028 KRW |
Company Info
Established as Woocheon Pharmaceutical in 1973, this company changed its name to Hana Pharmaceutical in 1996 and was listed in 2018. It leads the market with strengths in narcotic analgesics and anesthetics, conducting specialty pharmaceutical businesses with over 380 health insurance-listed medicines. The company operates a manufacturing plant in Hwaseong, Gyeonggi-do, and an R&D center in Pangyo. It is expanding production through new injectable plant certification and focusing on developing biosimilars and DDS-based improved new drugs. Hana Pharmaceutical was founded in 1978 and is headquartered in Hwaseong-si, Gyeonggi-do.